Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone vs Morphine for Analgesia in Lung Tumor Ablation
NCT05848635Phase 4Unknown
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- May 2023
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of hydromorphone in procedural pain, sponsored by Shandong Provincial Qianfoshan Hospital. Status: unknown.
02
Drugs
hydromorphone
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT05848635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05848635.